1.
Am J Transplant
; 21(4): 1629-1632, 2021 04.
Artículo
en Inglés
| MEDLINE
| ID: mdl-33047475
RESUMEN
To date, little is known about the duration and effectiveness of immunity as well as possible adverse late effects after an infection with SARS-CoV-2. Thus it is unclear, when and if liver transplantation can be safely offered to patients who suffered from COVID-19. Here, we report on a successful liver transplantation shortly after convalescence from COVID-19 with subsequent partial seroreversion as well as recurrence and prolonged shedding of viral RNA.